
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6729668
[patent_doc_number] => 20030185858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Immunogenic HBc chimer particles stabilized with an N-terminal cysteine'
[patent_app_type] => new
[patent_app_number] => 10/082014
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 31673
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 297
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082014 | Immunogenic HBc chimer particles stabilized with an N-terminal cysteine | Feb 20, 2002 | Abandoned |
Array
(
[id] => 252375
[patent_doc_number] => 07579007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Production of “biological carriers” for induction of immune responses and inhibition of viral replication'
[patent_app_type] => utility
[patent_app_number] => 10/468047
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6978
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468047 | Production of “biological carriers†for induction of immune responses and inhibition of viral replication | Feb 11, 2002 | Issued |
Array
(
[id] => 6765706
[patent_doc_number] => 20030100106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Baculovirus produced Plasmodium falciparum vaccine'
[patent_app_type] => new
[patent_app_number] => 10/062809
[patent_app_country] => US
[patent_app_date] => 2002-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 29002
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100106.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062809 | Baculovirus produced Plasmodium falciparum vaccine | Jan 31, 2002 | Abandoned |
Array
(
[id] => 6851046
[patent_doc_number] => 20030143249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Method of treating pain'
[patent_app_type] => new
[patent_app_number] => 10/062954
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3768
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062954
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062954 | Method of treating pain | Jan 30, 2002 | Issued |
Array
(
[id] => 675539
[patent_doc_number] => 07087376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-08
[patent_title] => 'Detection and identification of bacterial strains'
[patent_app_type] => utility
[patent_app_number] => 10/060618
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4804
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/087/07087376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060618 | Detection and identification of bacterial strains | Jan 29, 2002 | Issued |
Array
(
[id] => 6745646
[patent_doc_number] => 20030022829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Novel antiviral activities primate theta defensins and mammalian cathelicidins'
[patent_app_type] => new
[patent_app_number] => 10/060102
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17030
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060102
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060102 | Novel antiviral activities primate theta defensins and mammalian cathelicidins | Jan 28, 2002 | Abandoned |
Array
(
[id] => 930942
[patent_doc_number] => 06979446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-27
[patent_title] => 'Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections'
[patent_app_type] => utility
[patent_app_number] => 10/056052
[patent_app_country] => US
[patent_app_date] => 2002-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15665
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/979/06979446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056052 | Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections | Jan 27, 2002 | Issued |
| 09/914669 | Herpes simplex virus reactivation model | Jan 24, 2002 | Abandoned |
Array
(
[id] => 455729
[patent_doc_number] => 07244438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Uses for polycationic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/250953
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6190
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250953 | Uses for polycationic compounds | Jan 6, 2002 | Issued |
| 09/937857 | Influenza virus hemagglutinin-binding peptides | Jan 3, 2002 | Abandoned |
Array
(
[id] => 6683345
[patent_doc_number] => 20030119209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Diagnostic methods and devices'
[patent_app_type] => new
[patent_app_number] => 10/026314
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11592
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119209.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026314 | Diagnostic methods and devices | Dec 20, 2001 | Abandoned |
Array
(
[id] => 6711810
[patent_doc_number] => 20030171559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'G-CSF analog compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/032108
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 19704
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 53
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171559.pdf
[firstpage_image] =>[orig_patent_app_number] => 10032108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/032108 | G-CSF analog compositions and methods | Dec 19, 2001 | Issued |
Array
(
[id] => 7219185
[patent_doc_number] => 20050260559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Assay for anti-viral agent'
[patent_app_type] => utility
[patent_app_number] => 10/450342
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3803
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260559.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450342
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450342 | Assay for anti-viral agent | Dec 11, 2001 | Issued |
Array
(
[id] => 1085573
[patent_doc_number] => 06830917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-14
[patent_title] => 'Method of isolation and purification of trypsin from pronase protease and use thereof'
[patent_app_type] => B2
[patent_app_number] => 10/006223
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9260
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/830/06830917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006223 | Method of isolation and purification of trypsin from pronase protease and use thereof | Dec 9, 2001 | Issued |
Array
(
[id] => 7286641
[patent_doc_number] => 20040146854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Attenuated forms of bovine viral diarrhea virus'
[patent_app_type] => new
[patent_app_number] => 09/989933
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10737
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146854.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989933
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989933 | Attenuated forms of bovine viral diarrhea virus | Nov 20, 2001 | Abandoned |
Array
(
[id] => 6017071
[patent_doc_number] => 20020103212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Pharmaceutical compositions containing anti-fas antibody'
[patent_app_type] => new
[patent_app_number] => 09/989620
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9073
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103212.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989620
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989620 | Pharmaceutical compositions containing anti-Fas antibody | Nov 19, 2001 | Issued |
Array
(
[id] => 6774258
[patent_doc_number] => 20030017596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Use of parvovirus capsid particles in the inhibition of cell proliferation and migration'
[patent_app_type] => new
[patent_app_number] => 09/991433
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18006
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017596.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991433
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991433 | Use of parvovirus capsid particles in the inhibition of cell proliferation and migration | Nov 15, 2001 | Issued |
Array
(
[id] => 679144
[patent_doc_number] => 07083787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Yeast-dendritic cell vaccines and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/991363
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20190
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/083/07083787.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991363 | Yeast-dendritic cell vaccines and uses thereof | Nov 14, 2001 | Issued |
Array
(
[id] => 7149912
[patent_doc_number] => 20040171132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF'
[patent_app_type] => new
[patent_app_number] => 09/993777
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 24864
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171132.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993777 | Recombinant infectious laryngotracheitis virus and uses thereof | Nov 5, 2001 | Issued |
Array
(
[id] => 6870099
[patent_doc_number] => 20030082788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Recombinant infectious laryngotracheitis virus and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/994064
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25282
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082788.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994064 | Recombinant infectious laryngotracheitis virus and uses thereof | Nov 5, 2001 | Issued |